Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank64
3Y CAGR-19.6%
5Y CAGR-10.8%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-19.6%/yr
vs +17.5%/yr prior
5Y CAGR
-10.8%/yr
Recent deceleration
Acceleration
-37.1pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.76% | +461.5% |
| 2024 | -0.76% | -124.4% |
| 2023 | 3.13% | -41.1% |
| 2022 | 5.31% | +24.7% |
| 2021 | 4.26% | -12.7% |
| 2020 | 4.87% | +83.4% |
| 2019 | 2.66% | -4.7% |
| 2018 | 2.79% | +77.6% |
| 2017 | 1.57% | +56.9% |
| 2016 | 1.00% | - |